Skip to content

4549.T

EIKEN CHEMICAL CO.,LTD.

プライム · 医薬品 · 医薬品 · JP

JPY 2,324.00
−0.21%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue41.9B41.9B40.5B40.1B43.3B
Cost of Revenue6.1B25.7B24.0B23.3B22.8B
Gross Profit4.1B16.2B16.5B16.7B20.5B
Operating Expenses
R&D Expense
SG&A Expense3.3B13.3B13.5B13.3B13.0B
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses3.3B13.3B13.5B13.3B13.0B
Cost and Expenses39.0B39.0B37.5B36.7B35.8B
Operating Income (EBIT)2.9B2.9B3.0B3.4B7.5B
Non-Operating
Interest Income4.0M17.0M14.0M8.0M15.0M
Interest Expense4.0M29.0M17.0M17.0M16.0M
Net Interest Income(12.0M)(3.0M)(9.0M)(1.0M)
Other Non-Op Income/Expense13.0M(75.0M)199.0M191.0M112.0M
Non-Operating Income (excl Interest)41.0M147.0M221.0M276.0M139.0M
EBT (Pre-Tax Income)814.0M4.8B3.0B3.5B7.6B
Income Tax Expense214.0M1.1B763.0M869.0M1.9B
Bottom Line
Net Income3.7B3.7B2.2B2.6B5.7B
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income3.7B3.7B2.2B2.6B5.7B
Per Share
Basic EPS¥113¥112¥65¥72¥155
Diluted EPS¥113¥112¥64¥71¥154
Revenue Per Share¥1,271¥1,271¥1,179¥1,090¥1,171
Shares
Basic Shares Outstanding33.0M33.0M34.4M36.7M37.0M
Diluted Shares Outstanding
Profitability Metrics
EBITDA5.5B5.6B5.7B9.6B
D&A2.5B2.6B2.3B2.1B
EBIT2.9B2.9B3.0B3.4B7.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026